Where we stand

被引：0
|
作者：
不详
机构：
来源：
LANCET | 1943年 / 1卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：713 / 714
页数：2
相关论文
共 50 条
  • [31] Homocysteine research - where do we stand and where are we going?
    Herrmann, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (10) : 977 - 979
  • [32] Paediatric and Perinatal Epidemiology: Where We Stand, and Where Are We Headed?
    Ananth, Cande V.
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2017, 31 (01) : 1 - 3
  • [33] Cushing disease: Where do we stand, where are we heading?
    Maria Fleseriu
    Stephan Petersenn
    Pituitary, 2015, 18 : 179 - 180
  • [34] Diabetes Care in Iran: Where We Stand and Where We Are Headed
    Noshad, Sina
    Afarideh, Mohsen
    Heidari, Behnam
    Mechanick, Jeffrey I.
    Esteghamati, Alireza
    ANNALS OF GLOBAL HEALTH, 2015, 81 (06): : 839 - 850
  • [35] Rabies vaccines: where do we stand, where are we heading?
    Kaur, Manpreet
    Garg, Rajni
    Singh, Samer
    Bhatnagar, Rakesh
    EXPERT REVIEW OF VACCINES, 2015, 14 (03) : 369 - 381
  • [36] SYMPOSIA IN CHROMATOGRAPHY - WHERE DO WE STAND AND WHERE ARE WE HEADING
    BERTSCH, W
    HRC-JOURNAL OF HIGH RESOLUTION CHROMATOGRAPHY, 1989, 12 (06): : 353 - 353
  • [37] Gephyrin: where do we stand, where do we go?
    Fritschy, Jean-Marc
    Harvey, Robert J.
    Schwarz, Guenter
    TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 257 - 264
  • [38] Addictive behaviors: where do we stand, and where are we going?
    Thibaut, Florence
    Hoehe, Margret
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2017, 19 (03) : 215 - 215
  • [39] ENDOCRINE THERAPY - WHERE DO WE STAND AND WHERE ARE WE GOING
    SCHRODER, FH
    CANCER SURVEYS, 1991, 11 : 177 - 194
  • [40] GABA and schizophrenia: Where we stand and where we need to go
    Glausier, Jill R.
    Lewis, David A.
    SCHIZOPHRENIA RESEARCH, 2017, 181 : 2 - 3
12345